LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
37.83
-3.08 (-7.53%)
At close: Aug 15, 2025, 3:59 PM
39.27
3.81%
After-hours: Aug 15, 2025, 07:32 PM EDT

LENZ Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.77M -69.97M -101.05M -70.76M
Depreciation & Amortization
58K 15K 8.35M 734K
Stock-Based Compensation
6.37M 1.34M 721K 196K
Other Working Capital
-8.81M 8.55M -7.4M -4.32M
Other Non-Cash Items
-2.95M -1.18M 11.93M 19.32M
Deferred Income Tax
n/a n/a n/a 161K
Change in Working Capital
-13.09M 9.41M -7.21M -2.5M
Operating Cash Flow
-59.39M -60.38M -87.98M -52.85M
Capital Expenditures
-468K -30K -6.59M -5.74M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-241.91M -52.09M -405.52M n/a
Sales Maturities Of Investments
87.9M 22.5M 170.25M n/a
Other Investing Acitivies
n/a 1.9M n/a n/a
Investing Cash Flow
-154.48M -29.62M -241.86M -5.74M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -67K -79K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
119.49M -2.28M 129K 306K
Financial Cash Flow
199M 80.7M 597K 417.47M
Net Cash Flow
-14.87M -9.3M -329.25M 357.16M
Free Cash Flow
-59.86M -60.41M -94.57M -58.59M